When breaks get hot: inflammatory signaling in BRCA1/2-mutant cancers

MATM van Vugt, EE Parkes - Trends in cancer, 2022 - cell.com
Genomic instability and inflammation are intricately connected hallmark features of cancer.
DNA repair defects due to BRCA1/2 mutation instigate immune signaling through the …

DNA damage follows repair factor depletion and portends genome variation in cancer cells after pore migration

J Irianto, Y Xia, CR Pfeifer, A Athirasala, J Ji, C Alvey… - Current biology, 2017 - cell.com
Migration through micron-size constrictions has been seen to rupture the nucleus, release
nuclear-localized GFP, and cause localized accumulations of ectopic 53BP1—a DNA repair …

Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma

DG McFadden, K Politi, A Bhutkar… - Proceedings of the …, 2016 - National Acad Sciences
Genetically engineered mouse models (GEMMs) of cancer are increasingly being used to
assess putative driver mutations identified by large-scale sequencing of human cancer …

[HTML][HTML] BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance

R Drost, P Bouwman, S Rottenberg, U Boon, E Schut… - Cancer cell, 2011 - cell.com
Hereditary breast cancers are frequently caused by germline BRCA1 mutations. The BRCA1
C61G mutation in the BRCA1 RING domain is a common pathogenic missense variant …

Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers

MA Vollebergh, J Jonkers, SC Linn - Cellular and molecular life sciences, 2012 - Springer
Breast and ovarian cancer are among the most common malignancies diagnosed in women
worldwide. Together, they account for the majority of cancer-related deaths in women. These …

BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1

R Drost, KK Dhillon, H Van Der Gulden… - The Journal of …, 2016 - Am Soc Clin Investig
Heterozygous germline mutations in breast cancer 1 (BRCA1) strongly predispose women
to breast cancer. BRCA1 plays an important role in DNA double-strand break (DSB) repair …

Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy

MA Vollebergh, EH Lips, PM Nederlof… - Breast Cancer …, 2014 - Springer
Introduction BRCA-mutated breast cancer cells lack the DNA-repair mechanism
homologous recombination that is required for error-free DNA double-strand break (DSB) …

Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer

S Annunziato, JR de Ruiter, L Henneman… - Nature …, 2019 - nature.com
BRCA1-mutated breast cancer is primarily driven by DNA copy-number alterations (CNAs)
containing large numbers of candidate driver genes. Validation of these candidates requires …

Identifying and targeting sporadic oncogenic genetic aberrations in mouse models of triple-negative breast cancer

H Liu, CJ Murphy, FA Karreth, KB Emdal, FM White… - Cancer discovery, 2018 - AACR
Triple-negative breast cancers (TNBC) are genetically characterized by aberrations in TP53
and a low rate of activating point mutations in common oncogenes, rendering it challenging …

Interaction with PALB2 is essential for maintenance of genomic integrity by BRCA2

SA Hartford, R Chittela, X Ding, A Vyas, B Martin… - PLoS …, 2016 - journals.plos.org
Human breast cancer susceptibility gene, BRCA2, encodes a 3418-amino acid protein that
is essential for maintaining genomic integrity. Among the proteins that physically interact …